CRISPR
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade CRISPR 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CRSP
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.
CEOSamarth Kulkarni
CEOSamarth Kulkarni
Employees393
Employees393
HeadquartersZug, Zug
HeadquartersZug, Zug
Founded2013
Founded2013
Employees393
Employees393
CRSP Key Statistics
Market cap5.42B
Market cap5.42B
Price-Earnings ratio-10.19
Price-Earnings ratio-10.19
Dividend yield—
Dividend yield—
Average volume2.15M
Average volume2.15M
High today$59.15
High today$59.15
Low today$56.01
Low today$56.01
Open price$58.14
Open price$58.14
Volume1.66M
Volume1.66M
52 Week high$78.48
52 Week high$78.48
52 Week low$30.04
52 Week low$30.04
Stock Snapshot
As of today, CRISPR(CRSP) shares are valued at $57.00. The company's market cap stands at 5.42B, with a P/E ratio of -10.19.
On 2025-12-06, CRISPR(CRSP) stock traded between a low of $56.01 and a high of $59.15. Shares are currently priced at $57.00, which is +1.8% above the low and -3.6% below the high.
The CRISPR(CRSP)'s current trading volume is 1.66M, compared to an average daily volume of 2.15M.
In the last year, CRISPR(CRSP) shares hit a 52-week high of $78.48 and a 52-week low of $30.04.
In the last year, CRISPR(CRSP) shares hit a 52-week high of $78.48 and a 52-week low of $30.04.
Analyst ratings
57%
of 30 ratingsBuy
56.7%
Hold
40%
Sell
3.3%
People also own
Based on the portfolios of people who own CRSP. This list is generated using Robinhood data, and it’s not a recommendation.